Live-attenuated Respiratory Syncytial Virus Vaccines: Time for the Next Step
- PMID: 32986467
- PMCID: PMC7924581
- DOI: 10.1164/rccm.202009-3431ED
Live-attenuated Respiratory Syncytial Virus Vaccines: Time for the Next Step
Comment on
-
Live-attenuated Vaccines Prevent Respiratory Syncytial Virus-associated Illness in Young Children.Am J Respir Crit Care Med. 2021 Mar 1;203(5):594-603. doi: 10.1164/rccm.202005-1660OC. Am J Respir Crit Care Med. 2021. PMID: 32871092 Free PMC article.
References
-
- Griffin MP, Yuan Y, Takas T, Domachowske JB, Madhi SA, Manzoni P, et al. Nirsevimab Study Group. Single-dose nirsevimab for prevention of RSV in preterm infants. N Engl J Med. 2020;383:415–425. - PubMed
-
- Sadoff J, De Paepe E, Haazen W, Omoruyi E, Bastian AR, Comeaux C, et al. Safety and immunogenicity of the Ad26.RSV.preF investigational vaccine coadministered with an influenza vaccine in older adults. J Infect Dis. [online ahead of print] 26 Aug 2020; DOI: 10.1093/infdis/jiaa409. - PubMed
-
- PATH. RSV vaccine and mAb snapshot. Vaccine Resour Libr. 2020 [updated 2020 Mar 26; accessed 2020 Sep 4]. Available from: https://www.path.org/resources/rsv-vaccine-and-mab-snapshot/
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical